Matrix metallopeptidase 9 targeted by hsa‐miR‐494 promotes silybin‐inhibited osteosarcoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|57|2|262-271

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.57, Iss.2, 2018-02, pp. : 262-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CRKL promotes lung cancer cell invasion through ERK‐MMP9 pathway

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E35-E44

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐200c‐3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 295-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

New insights into the pathology of pulmonary hypertension: implication of the miR‐210/ISCU1/2/Fe‐S axis

By  

EMBO Molecular Medicine, Vol. 7, Iss. 6, 2015-06 ,pp. : 689-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐96‐5p influences cellular growth and is associated with poor survival in colorectal cancer patients

By  

Molecular Carcinogenesis, Vol. 54, Iss. 11, 2015-11 ,pp. : 1442-1450

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐130b suppresses prostate cancer metastasis through down‐regulation of MMP2

By  

Molecular Carcinogenesis, Vol. 54, Iss. 11, 2015-11 ,pp. : 1292-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite